Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in patients with atrial fibrillation and type 2 diabetes mellitus

被引:0
|
作者
Oh, Y. S. [1 ]
Choi, Y. [1 ]
Kim, S. H. [1 ]
Kim, S. H. [1 ]
Park, S. Y. [1 ]
Kim, H. J. [1 ]
机构
[1] Seoul St Marys Hosp, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes
    Suissa, Karine
    Schneeweiss, Sebastian
    Douros, Antonios
    Yin, Hui
    Patorno, Elisabetta
    Azoulay, Laurent
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
  • [22] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Weight in Type 2 Diabetes Mellitus and Therapeutic Regimen Recommendation
    Wang, Dong-Dong
    Mao, Yi-Zhen
    Yang, Yang
    Wang, Tian-Yun
    Zhu, Ping
    He, Su-Mei
    Chen, Xiao
    [J]. JOURNAL OF DIABETES RESEARCH, 2022, 2022
  • [23] Association between sodium-glucose cotransporter-2 inhibitors and arrhythmic outcomes in patients with diabetes and pre-existing atrial fibrillation
    Fichadiya, Akash
    Quinn, Amity
    Au, Flora
    Campbell, Dennis
    Lau, Darren
    Ronksley, Paul
    Beall, Reed
    Campbell, David J. T.
    Wilton, Stephen B.
    Chew, Derek S.
    [J]. EUROPACE, 2024, 26 (03):
  • [24] Renal effects of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and renal impairment
    Weir, Matthew R.
    [J]. POSTGRADUATE MEDICINE, 2019, : 367 - 375
  • [25] EFFECTS OF ADDING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS TO STANDARD CARE IN PATIENTS WITH TYPE 2 DIABETES
    Sharma, Abhishek
    Kamran, Haroon
    Goel, Sunny
    Mukherjee, Debabrata
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (03) : 734 - 735
  • [26] Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
    Eroglu, Talip E.
    Coronel, Ruben
    Souverein, Patrick C.
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (04) : 289 - 295
  • [27] EFFECTS OF ADDING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS TO STANDARD CARE IN PATIENTS WITH TYPE 2 DIABETES
    Sharma, A.
    Kamran, H.
    Goel, S.
    Mukherjee, D.
    [J]. CARDIOLOGY, 2017, 137 : 92 - 92
  • [28] Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
    Zhang, Allan
    Kalil, Ramsey
    Marzec, Alexander
    Coulter, Stephanie A.
    Virani, Salim
    Patel, Kershaw V.
    Segar, Matthew W.
    [J]. TEXAS HEART INSTITUTE JOURNAL, 2024, 51 (01)
  • [29] The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus
    Dong, Meiyuan
    Chen, Huiling
    Wen, Song
    Yuan, Yue
    Yang, Liling
    Xu, Dongxiang
    Zhou, Ligang
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 437 - 445
  • [30] Sodium-glucose cotransporter-2 inhibitors protect against atrial fibrillation in patients with heart failure
    Zhou, Lili
    Yang, Yuanyuan
    Han, Weixing
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 10887 - 10895